Review ArticleSynovial sarcoma: defining features and diagnostic evolution☆
Introduction
Synovial sarcoma (SS) is a malignant mesenchymal neoplasm with partial epithelial differentiation, that occurs predominantly in older children and young adults and that has been shown to occur at almost any anatomic site. Accounting for 5% to 10% of all soft tissue sarcomas [1], [2], [3], SS was originally named for its frequent occurrence in the soft tissue around large joints, particularly the knee, and was believed to be of synovial cell origin. It has now been documented in most areas of the body including viscera. Its occurrence within a joint is very rare [4], [5], [6], and as SS neither arise from nor differentiate toward synovium, the name is a historical error [7], [8]. A specific cell of origin is unknown and neural, myogenic, or multipotent mesenchymal stem cells have been considered as putative originators [9], [10], [11], [12]. Synovial sarcoma was initially recognized as a biphasic neoplasm with both epithelial and uniform spindle cell components, but it is now clear that there is considerable morphologic and immunohistochemical heterogeneity within this group of neoplasms. Although the 2 characteristic (spindle or epithelioid) cell types of SS are morphologically distinct, they are histogenetically similar. Synovial sarcoma is defined by the presence of the t(X;18)(p11.2;q11.2) translocation, involving the SS18 (formerly SYT) gene on chromosome 18 and one of several synovial sarcoma X (SSX) genes on chromosome X (usually SSX1 or SSX2), which is seen in more than 90% of SS and results in the formation of SS18-SSX fusion oncogenes. Synovial sarcoma is, perhaps, the most well established “translocation-associated sarcoma,” a neoplasm with defining genetics for which the diagnostic gold standard has long been the use of ancillary molecular and molecular cytogenetic diagnostic techniques, fluorescence in situ hybridization, or reverse transcription–polymerase chain reaction (RT-PCR). There is a large histologic spectrum, with SS showing significant morphologic overlap with a variety of neoplasms, from small round cell tumors to spindle cell sarcomas and carcinoma. We review here the clinicopathologic and genetic features of SS, with emphasis on the diagnostic spectrum and new molecular and immunohistochemical findings.
Section snippets
Clinical and radiologic features
Synovial sarcomas account for between 5% and 10% of all childhood, adolescent, and adult soft tissue sarcomas [1], [2], [3] and occur over a wide age range, having been reported in infants (including congenital cases) [13] and adults up to their eighth and ninth decades [14], [15]. However, SS is predominant in young adults between aged 15 and 40 years, with peak incidence in the third decade and 90% occurring before aged 60 years [7], [15]. Synovial sarcoma is the commonest
Prognosis and treatment
Synovial sarcoma is generally considered a high-grade, aggressive sarcoma, with 5- and 10-year survival rates of approximately 60% and 50%, respectively [60]. It is noted for its propensity for late local recurrence and metastasis, with the latter often occurring after more than 5 years [61]. Metastatic disease occurs in approximately 50% of patients [62] and is more common in adults [63]. Synovial sarcoma commonly metastasizes to the lungs and pleura (which are also known sites for primary
Histopathologic and immunohistochemical findings
Grossly, SS are multinodular masses, ranging in size from minute (<1 cm) to 15 cm in diameter. They can appear relatively well defined but infiltrate irregularly into the surrounding soft tissues and may be adherent to an adjacent tendon or neurovascular bundle [7]. The cut surface varies from solid, firm, and fleshy to smooth and glistening to tan, gritty, and calcified. Calcification is common, but it can be difficult to discern grossly. Occasionally, there is cyst formation, with smooth
Ultrastructure
Monophasic SS shows closely packed cells with focal poorly formed intercellular junctions, along with intercellular spaces with processes present to varying degrees [108], some microvilli, fragments of external lamina, and variable amounts of rough endoplasmic reticulum that may resemble fibroblasts. Biphasic SS shows glands enclosed in continuous external lamina, with well-organized, true epithelial tight junctions [133], [134], junctional complexes, surface microvilli, and tonofilaments.
Molecular genetic and cytogenetic findings
Synovial sarcomas harbor a highly specific, usually balanced and reciprocal t(X;18)(p11.2;q11.2) translocation, in which the SS18 (formerly SYT) gene (at 18q11) fuses with SSX genes: SSX1, SSX2, or rarely SSX4[135] (all at Xp11), leading to the generation of SS18-SSX fusion oncogenes [136], [137], [138], [139]. Nine SSX genes (SSX1-9) have been described to date and are highly homologous [14]. SS18-SSX can be detected in more than 95% of SS [140], for which it is specific and has been seen in
Differential diagnosis
The differential diagnosis of SS is wide and varies according to the specific morphologic pattern. Carcinosarcoma or sarcomatoid carcinoma can be particularly difficult to distinguish from SS, and monophasic epithelial SS may be overlooked as well differentiated adenocarcinoma. Patients with metastatic carcinoma tend to be older than those with SS and often have a history of previous or primary carcinoma. Carcinoma may show features of dysplasia or in situ carcinomatous change in the overlying
Conclusions
Synovial sarcoma shows a wide spectrum of morphologic and immunophenotypic variation, which, along with its propensity to occur at almost any anatomic site, can result in significant diagnostic difficulty. As the subclassification of sarcomas becomes increasingly complex with the incorporation of molecular characteristics alongside histology and immunohistochemistry into routine diagnostic pathology, SS represents a tumor with defining genetics whose molecular features were identified at an
Acknowledgments
We acknowledge support from the National Institute for Health Research Royal Marsden Hospital/Institute of Cancer Research Biomedical Research Centre.
References (189)
Synovial sarcoma
Ann Diagn Pathol
(1998)- et al.
A conditional mouse model of synovial sarcoma: insights into a myogenic origin
Cancer Cell
(2007) - et al.
Radiation-associated synovial sarcoma
Hum Pathol
(1997) - et al.
Radiation-associated synovial sarcoma: clinicopathologic and molecular analysis of two cases
Mod Pathol
(2002) - et al.
Primary monophasic synovial sarcoma of the duodenum with SYT/SSX2 type of translocation
Hum Pathol
(2007) - et al.
Synovial sarcoma of bone delineated by spectral karyotyping
Lancet
(1997) - et al.
Synovial sarcoma of nerve
Hum Pathol
(2011) - et al.
Synovial sarcomas usually metastasize after >5 years: a multicenter retrospective analysis with minimum follow-up of 10 years for survivors
Ann Oncol
(2011) - et al.
Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: chondrosarcoma and other cartilaginous neoplasms
Cancer Genet Cytogenet
(2003) - et al.
Prognostic factors in advanced synovial sarcoma: an analysis of 104 patients treated at the Royal Marsden Hospital
Ann Oncol
(2005)
Histology- and non-histology-driven therapy for treatment of soft tissue sarcomas
Ann Oncol
Malignant hemangiopericytoma and other sarcomas with hemangiopericytoma-like pattern
Pathol Res Pract
Detection of SS18-SSX fusion transcripts in formalin-fixed paraffin-embedded neoplasms: analysis of conventional RT-PCR, qRT-PCR and dual color FISH as diagnostic tools for synovial sarcoma
Mod Pathol
Ossifying synovial sarcoma
Pathol Res Pract
Long-term treatment outcomes for patients with synovial sarcoma: a 40-year experience at the University of Florida
Am J Clin Oncol
Overview of sarcomas in the adolescent and young adult population
J Pediatr Hematol Oncol
Comparing children and adults with synovial sarcoma in the Surveillance, Epidemiology, and End Results program, 1983 to 2005: an analysis of 1268 patients
Cancer
Intraarticular synovial sarcoma
Am J Surg Pathol
Intra-articular calcifying synovial sarcoma mimicking synovial chondromatosis
Skeletal Radiol
Synovial sarcoma arising in an anatomical bursa
Virchows Arch A Pathol Anat Histol
Synovial sarcoma lack synovial differentiation
Histopathology
Neuronal differentiation of synovial sarcoma and its therapeutic application
Clin Orthop Relat Res
Synovial sarcoma is a stem cell malignancy
Stem Cells
Reprogramming of mesenchymal stem cells by the synovial sarcoma-associated oncogene SYT-SSX2
Oncogene
First case report of a fetal synovial sarcoma confirmed by molecular detection of SYT-SSX fusion gene transcripts
Am J Perinatol
Recurrent and novel SS18-SSX fusion transcripts in synovial sarcoma: description of three new cases
Tumour Biol
Synovial sarcoma in older patients: clinicopathological analysis of 32 cases with emphasis on unusual histological features
Histopathology
Synovial sarcoma in patients under 20 years of age: a multicenter study with a minimum follow-up of 10 years
J Child Orthop
Synovial sarcomas of three children in the first decade: clinicopathological and molecular findings
Pathol Int
Synovial sarcoma in children and adolescents
J Pediatr Hematol Oncol
Sparing strategy does not compromise prognosis in pediatric localized synovial sarcoma: experience of the International Society of Pediatric Oncology, Malignant Mesenchymal Tumors (SIOP-MMT) Working Group
Pediatr Blood Cancer
Radiation-associated synovial sarcoma of the lung following radiotherapy for pulmonary metastasis of Wilms' tumour
Histopathology
Synovial sarcoma associated with total hip replacement. A case report
J Bone Joint Surg Am
Synovial sarcoma: imaging features of common and uncommon primary sites, metastatic patterns, and treatment response
AJR Am J Roentgenol
Synovial sarcoma: MR imaging findings in 34 patients
AJR Am J Roentgenol
Radiologic evaluation of soft-tissue masses: a current perspective
AJR Am J Roentgenol
Synovial sarcomas of the head and neck: MR findings
AJR Am J Roentgenol
Minute synovial sarcomas of the hands and feet: a clinicopathologic study of 21 tumors less than 1 cm
Am J Surg Pathol
Primary cutaneous synovial sarcoma: a case report
Am J Dermatopathol
Synovial sarcoma involving the head: analysis of 36 cases with predilection to the parotid and temporal regions
Am J Surg Pathol
Primary synovial sarcomas of the mediastinum: a clinicopathologic, immunohistochemical, and ultrastructural study of 15 cases
Am J Surg Pathol
A biphasic tumor of the mediastinum with features of synovial sarcoma. A report of four cases
Am J Surg Pathol
Cystic primary pulmonary synovial sarcoma presenting as recurrent pneumothorax: report of 4 cases
Am J Surg Pathol
Synovial sarcoma of the pleura and its differentiation from other primary pleural tumours: a clinicopathological and immunohistochemical review of three cases
Histopathology
Biphasic synovial sarcomas arising in the pleural cavity. A clinicopathologic study of five cases
Am J Surg Pathol
Hemangiopericytoma-like synovial sarcoma of the lumbar spine. Case report
J Neurosurg Spine
Synovial sarcoma of the heart
Histopathology
Mediastinal synovial sarcoma
Thorac Cardiovasc Surg
Intra-abdominal synovial sarcoma: a clinicopathological study
Histopathology
Synovial sarcoma of the stomach: a clinicopathologic, immunohistochemical, and molecular genetic study of 10 cases
Am J Surg Pathol
Cited by (210)
Synovial Sarcoma of the Gastrointestinal Tract
2024, Modern PathologyMultidisciplinary management of recurrent synovial sarcoma of the chest wall
2023, North American Spine Society JournalLimb conservation surgery in biphasic synovial sarcoma of thigh with vascular involvement: A race against time
2023, International Journal of Surgery Case ReportsTumor size and surgical margins are important prognostic factors of synovial sarcoma - A retrospective study
2023, Journal of OrthopaedicsSynovial sarcoma: cytopathology of 51 cases highlighting the application of ancillary molecular testing
2023, Journal of the American Society of CytopathologyApplication of immunohistochemical studies in diagnosing emerging superficial mesenchymal neoplasms
2023, Seminars in Diagnostic Pathology
- ☆
Disclosures: The authors have no conflicts of interest or funding to disclose.